Freedman, Samuel F.
Johnston, Carrie
Faragon, John J.
Siegler, Eugenia L. http://orcid.org/0000-0001-9449-5873
Del Carmen, Tessa
Funding for this research was provided by:
National Institutes of Health (TL1 TR000459)
Gilead Sciences (IN-US-311-4182)
National Institute of Allergy and Infectious Diseases (T32 AI007613)
Article History
Received: 13 October 2018
Accepted: 20 November 2018
First Online: 6 December 2018
Change Date: 20 May 2019
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake.
Compliance with ethical standards
:
: Dr. Siegler receives support from Gilead Sciences for an investigator-initiated study. Dr. Faragon is on the speakers’ bureaus of AbbVie, Gilead Sciences, Merck, and Janssen Pharmaceutical. Drs. Freedman, Johnston, and Del Carmen report no conflicts of interest.
: The preparation of this review did not involve human or animal participants.
: No informed consent was required.